Results 191 to 200 of about 797,094 (260)

Prehospital prediction of survival after out-of-hospital cardiac arrest using point-of-care testing and vital signs: a prospective, multinational study. [PDF]

Sci Rep
Lopez-Ballesteros A, Sanz-García A, Alonso E, Delgado-Benito JF, Eichinger M, López-Izquierdo R, Isasi I, Sánchez-Soberón I, Del Pozo Vegas C, de Groot B, Martín-Conty JL, Polonio-López B, Martín-Rodríguez F.   +12 more
europepmc   +1 more source

Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease

FEBS Open Bio, EarlyView.
Repair of neuronal DNA damage in Alzheimer's disease by KCL‐286. (A) Amyloid‐β oligomers and plaques impair neuronal DNA repair pathways, leading to DNA double‐strand breaks and glial activation. (B) KCL‐286 activates RARβ/RXR signalling via retinoic acid response elements (RAREs), associated with increased BRCA1 expression, enhanced DNA repair and ...
Natasha Hill, Hassan Yousef Othman AlMuallim, Elouisa Maddock, Carl Hobbs, Earl Clarke, Maria B. Goncalves, Jonathan P. T. Corcoran   +6 more
wiley   +1 more source

Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testing.

Blood Glob Hematol
Hulikova A, Wang Z, Broomfield H, Robinson J, Healy M, Figueroa-Mujíca RJ, Gamboa D, Torres K, Ammanath G, Hartono D, Siow RC, Engledow S, Srinamon K, Ghose A, Plewes K, Dondorp AM, Roy NBA, Villafuerte FC, Khan H, Swietach P.   +19 more
europepmc   +1 more source

Long-term real-world performance of the Bayer Contour TS point-of-care testing glucose meters. [PDF]

Sci Rep
Zhao Z, Lang Y, Wang T, Zhao X, Li R, Li X, Xiong P, Li R.   +7 more
europepmc   +1 more source

Assessment of cardiac biomarker "point-of-care" testing as postmortem diagnostic tool. [PDF]

Int J Legal Med
Federspiel JM, Kettner M, Potente S, Heinbuch S, Lux C, Verhoff MA, Ramsthaler F.   +6 more
europepmc   +1 more source

From Lab to Bedside Testing: Uncovering Gateways and Roadblocks to Syndromic Multiplex Point-of-Care Testing for Infectious Diseases in Canadian Hospitals. [PDF]

Healthc Manage Forum
Augustyniak M, Isber J, Shaw J, Weiss K, Lazure P.   +4 more
europepmc   +1 more source

CGM accuracy and reliability compared to point of care testing in older inpatients with comorbid type 2 diabetes and cognitive impairment

Donat Ergin B, Mattishent K, Minihane A, Holt RI, Murphy HR, Dhatariya K, Hornberger M.   +6 more
europepmc   +1 more source